Join as a Volunteer
Our purpose will always be
"Save and improve lives through translating research into accessible healthcare solutions"
Our Three Cores
One Integrated organization for health solutions.
CRO: Clinical Research Solutions →
01 — CRO Clinical Research Solutions
MARC-CRO supports clinical research across the development of lifecycle, from study start-up and regulatory submissions to clinical operations, data management, biostatistics, quality, and reporting. MARC-CRO was established in 2022 licensed by Egyptian Drug Authority (EDA) and the Supreme Council for Review of Ethics of Clinical Medical Research (SCCRE) and operates within the Egyptian clinical research and regulatory environment, supporting studies across specialty areas, rare diseases, and medical devices.
Bioequivalence Solutions→
02 — Bioequivalence
Clinical, Bioanalytical & PK Expertise MARC-BE is an EDA-licensed and GCC accredited Bioequivalence Center , combining comprehensive clinical infrastructure to deliver complex and large-scale bioequivalence studies. Our 66-bed clinical unit, supported by ICU facilities and six LC-MS/MS systems including the SCIEX Triple Quad 7500+, enables precise, reliable study execution from clinical operations through bioanalysis, PK analysis, and regulatory support. And beyond conventional Bioequivalence studies, we offer Virtual Bioequivalence studies, PK/PD modeling, and model-informed development capabilities to support smarter study strategies and more efficient development decisions.
Bioscience Laboratories solutions→
03-Bioscience Laboratories
MARC Bioscience Laboratories are a leading provider of integrated basic and translational research. MARC's multidisciplinary team of scientists and researchers is dedicated to adopting cutting-edge technologies that can lead to patentable life-saving products. With a broad portfolio of bioscience research services and laboratory capabilities, MARC supports academic institutions, biotechnology companies, pharmaceutical organizations, healthcare researchers, and the wider scientific community. Our integrated approach provides the expertise, technologies, and infrastructure needed to transform scientific discoveries into meaningful real-world applications.
Our Solutions
MARC conducts high-impact basic, preclinical, and clinical research to translate scientific discoveries into practical medical applications, bridge the gap between research and healthcare, and advance standards of patient care.
All
Contract Research Organization
Bioscience Research Laboratories
Bioequivalence Center
01. Contract Research Organization (CRO)
Clinical research and development services across the study lifecycle, including clinical operations, data management, biostatistics, medical writing, safety, and pharmacovigilance.
02. Bioequivalence Center (MARC-BE)
Bioequivalence and bioavailability studies, comparative dissolution, pharmacokinetic calculations, and bioanalytical services.
03. Bioscience Research Laboratories (BioLabs)
Integrated basic and translational research, including genomics, bioinformatics, molecular biology, immunology, microbiology, cell culture, and nanotechnology.
05. Clinical Research Site (MEDAXIS)
Dedicated clinical research facilities supporting Phase I–IV studies and complex clinical investigations.
Who Can Partner with MARC?
MARC works with organizations across the healthcare and scientific ecosystem Our capabilities are designed to adapt to different project sizes, scientific requirements, and stages of development.
Pharmaceutical companies
Universities & Academic Institutions
Healthcare organizations
Clinical research sponsors
Medical devices companies
Every clinical study at MARC undergoes MARC ClinGuard
Our integrated clinical monitoring and quality assurance framework designed to safeguard participants, data integrity, protocol compliance, and GCP standards.
From study initiation to close-out, ClinGuard provides continuous oversight across our clinical trials, bioequivalence studies, and research projects, ensuring every study is conducted with consistency, transparency, and quality at every step.
We welcome collaboration opportunities with local, regional, and international sponsors looking for trusted monitoring support to
And for clinical studies we have MedAxis a dedicated Clinical Research Center.
A Dedicated Clinical Research Center Built for Complex Studies. MEDAXIS is MARC's dedicated clinical research center, providing a purpose-built environment for the execution of clinical trials with a strong focus on participant safety, operational readiness, and quality-driven research. Supporting Phase I to Phase IV clinical trials, MEDAXIS brings together dedicated infrastructure, experienced clinical teams, and structured research workflows to support sponsors throughout study execution.
Happening in MARC
PressRelease
Bioequivalence Unit receives GCC Accreditation.
PressRelease
MARC Host TCIS committee attendees on its premises
Event
MARC welcomes Prof. Abdel Nasser Singab,
Leadership Team
Dr. George M. Ragheb
CEO
Bioscience Research Team
Dr. Ramy Aziz
Biosciences Research Labs Head
Business Development Team
Dr. Walaaeldin Ahmed
Business Development Manager
CRO Team
Dr. Lydia Bahig
Clinical Project Lead
Bioscience Research Team
Dr. Suha Farraj
Genomics Senior Scientist
Bioscience Research Team
Dr. Samaa Shama
Cell Culture Scientist
Bioscience Research Team
Dr. Bishoy Maher
Microbiology Scientist
Bioequivalence Center Team
Dr. Iman Ahmed
Bioequivalence Head
Bioequivalence Center Team
Dr. Magy Aiad
Bioequivalence Center Manager
Bioequivalence Center Team
Dr. Hassan Mohamed
Bioequivalence Lab section Head
QA Team
Dr. Hanaa Mohamed
QA Section Head
A newly established integrative research center that aims to advance science by conducting research into interdisciplinary disease areas
Subscribe for our latest news and updates
Follow Us
